Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Its programs are focused on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome, CDKL5 Deficiency Disorders, and familial Parkinson's Disease. The company was founded on April 8, 1999 and is headquartered in Cherry Hill, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Vyant Bio Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Vyant Bio Inc market cap is $1.23M.
What is the 52-week high for Vyant Bio Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vyant Bio Inc 52 week high is $1.58 as of September 12, 2025.
What is the 52-week low for Vyant Bio Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vyant Bio Inc 52 week low is $0.141 as of September 12, 2025.
What is Vyant Bio Inc stock price today?
Vyant Bio Inc stock price today is $0.194.
What was Vyant Bio Inc stock price yesterday?
Vyant Bio Inc stock price yesterday was $0.18.
What is the PE ratio of Vyant Bio Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Vyant Bio Inc’s P/E ratio is -0.09.
What is the Price-to-Book ratio of Vyant Bio Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Vyant Bio Inc P/B ratio is 0.2728.
What is Vyant Bio Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Vyant Bio Inc's EBITDA is 0.07.
What is the 50-day moving average of Vyant Bio Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Vyant Bio Inc 50-day moving average is $0.1755.